wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-66FF6D74-47C2-48EC-A830-4BA3BB44478F
Q37604501-66FF6D74-47C2-48EC-A830-4BA3BB44478F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-66FF6D74-47C2-48EC-A830-4BA3BB44478F
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P2860
Q37604501-66FF6D74-47C2-48EC-A830-4BA3BB44478F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-66FF6D74-47C2-48EC-A830-4BA3BB44478F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30988cd2bfe631bb538ec8de038cdea724ea8fb5
P2860
Baricitinib in Patients with Refractory Rheumatoid Arthritis.